Mettler-Toledo International Inc. (NYSE:MTD – Get Free Report) has been assigned an average recommendation of “Reduce” from the eight analysts that are presently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $1,338.75.
A number of research analysts have recently commented on MTD shares. JPMorgan Chase & Co. upped their price target on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a report on Monday, August 5th. Robert W. Baird reduced their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. Wells Fargo & Company decreased their price target on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. Evercore ISI upped their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Finally, Stifel Nicolaus decreased their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research report on Monday, November 11th.
Get Our Latest Stock Analysis on Mettler-Toledo International
Mettler-Toledo International Price Performance
Mettler-Toledo International (NYSE:MTD – Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The business had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. Analysts anticipate that Mettler-Toledo International will post 40.39 earnings per share for the current year.
Insiders Place Their Bets
In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the company’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the sale, the director now directly owns 240 shares in the company, valued at $314,820. This represents a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.94% of the company’s stock.
Institutional Investors Weigh In On Mettler-Toledo International
Large investors have recently made changes to their positions in the company. Gateway Investment Advisers LLC bought a new position in Mettler-Toledo International in the 2nd quarter valued at $685,000. Swedbank AB bought a new stake in shares of Mettler-Toledo International during the first quarter valued at approximately $26,867,000. SG Americas Securities LLC increased its holdings in shares of Mettler-Toledo International by 52.9% in the second quarter. SG Americas Securities LLC now owns 4,516 shares of the medical instruments supplier’s stock valued at $6,312,000 after purchasing an additional 1,562 shares in the last quarter. Allspring Global Investments Holdings LLC raised its position in Mettler-Toledo International by 14.0% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,240 shares of the medical instruments supplier’s stock worth $1,860,000 after purchasing an additional 152 shares during the last quarter. Finally, Linden Thomas Advisory Services LLC lifted its holdings in Mettler-Toledo International by 212.2% during the 2nd quarter. Linden Thomas Advisory Services LLC now owns 1,308 shares of the medical instruments supplier’s stock worth $1,828,000 after buying an additional 889 shares in the last quarter. Institutional investors own 95.07% of the company’s stock.
Mettler-Toledo International Company Profile
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Further Reading
- Five stocks we like better than Mettler-Toledo International
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- What Are Growth Stocks and Investing in Them
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Bank Stocks – Best Bank Stocks to Invest In
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.